Ischaemia imaging in type 2 diabetic kidney transplant candidates - Is coronary angiography essential?

Nephrology Dialysis Transplantation

Volumn 22, Issue 8, 2007, Pages 2334-2338

  Gang, Sishir ^a   Dabhi, Manish ^a   Rajapurkar, Mohan Manohar ^a  

^a MULJIBHAI PATEL UROLOGICAL HOSPITAL   (India)

Author keywords

Coronary angiography; Dobutamine stress echocardiography; Kidney trnsplant; Type 2 diabetes mellitus

Indexed keywords

DOBUTAMINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; EPICARDIUM; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY;

ADRENERGIC BETA-AGONISTS; ADULT; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS;

EID: 34547830302     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm134     Document Type: Article

References (27)

1. United States Renal Disease System: USRDS 1996 Annual Data Report. National Institute of Health, Bethesda, MD. National Institute of Diabetes and Digestive and Kidney Disease.1996, pp. 85-94.
2. US Department of Health and Human Services: Morbidity and Mortality: Chartbook on Cardiovascular, Lung and Blood Disease. Department of Health and Human Services, Bethesda, MD, US, 1996.
3. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 [Suppl 3]: S112-S119
4. Kasiske W, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165
5. Kasiske LB, Cangro BC, Hariharan S, Hricik DE, Kerman HR et al. The evaluation of renal transplant candidates. Clinical practice guidelines. Am J Transplant 2001; 2 [Suppl 1]: S44-52
6. Schmidt A, Stefenelli T, Schuster E et al. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 2001; 37: 56-63
7. Koch M, Gradaus F, Schoebel FC et al. Relevance of conventional cardiovascular risk factors for prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997; 12: 1187-1191
8. Vanderberg BF, Rossen JD, Grover-McKay M et al. Evaluation of diabetic patients for renal and pancreas transplantation: Non-invasive screening for coronary disease using radionuclide methods. Transplantation 1996; 62: 1230-1235
9. Herzog CA, Marwick TH, Pheley AM, White WC, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33: 1080-1090
10. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993; 44: 617-621
11. De Lima JJ, Sabbaga E, Vieira ML et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42: 263-268
12. Ramanathan V, Goaral Simin, Helderman HJ et al. Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation. Transplantation 2005; 79: 1453-1458
13. Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 2207-2214
14. Secknus MA, Neiedermaier ON, Lauer MS, Marwick TH. Diagnostic and prognostic implications of left ventricular cavity obliteration response to dobutamine echocardiography. Am J Cardiol 1998; 81: 1318-1322
15. Vanderberg BF, Rossen JD, Grover-McKay M et al. Evaluation of diabetic patients for renal and pancreas transplantation: Non-invasive screening for coronary disease using radionuclide methods. Transplantation 1996; 62: 1230-1235
16. Marwick TH, Steinmuller DR, Underwood DA, Hobes RE, Go RT, Swift C, Braun WE. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end stage renal disease. Transplantation 1990; 49: 100-103
17. Bourdeau RJ, Strony JT, Du cret RP et al. Perfusion thalliurn imaging of type I diabetes patients with end stage renal disease. Comparison of oral and intravenous dipyridamole administration. Radiology 1990; 175:1459-1463
18. Fuster D, Margina J, Ricart MJ et al. Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy. Transplant Int 2000; 13: 327-332
19. Bates JR, Sawada SJ, Segar DS et al. Evaluation using dobutamine stress echocardiography in patients with insulin dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996; 77: 175-179
20. Rabbat CG, Treleaven DJ, Russell JD et al. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis. J Am Soc Nephrol 2003; 14: 431-439
21. Ohtake T, Kobayashi S. Moriya Hidekazu et al. High Prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148
22. Fishbane S. Cardiovascular risk evaluation before kidney transplantation. J Am Soc Nephrol 2005; 16: 843-845
23. Sicari R, Cortigiani L, Bigi R et al. Prognostic value of pharmacological stress echocardiography is affected by concomitant antiischemic therapy at the time of testing. Circulation 2004; 109: 2428-2431
24. Bartunek J, Marwick TH, Rodrigues AC et al. Dobutamine induced wall motion abnormalities: Correlation with myocardial fractional flow reserve and quantitative coronary angiography. JACC 1996; 27: 1429-1436
25. Sawada SG, Segar DS, Ryan T et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605-1614
26. Chaowalit N, Arruda AL, McCully RD et al. Dobutamine stress echocardiography in patients with diabetes mellitus: Enhanced prognostic prediction using a simple risk score. JACC 2006; 47: 1029-1036
27. Chaowalit N, McCully RB, Callahan MJ et al. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. European Heart Journal 2006; 27: 3039-3044